Latest Breaking News On - Path lung - Page 1 : comparemela.com

bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath Lung Sales and Increased Laboratory Volumes

bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath Lung Sales and Increased Laboratory Volumes
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesNorth carolinaNew jerseySandeep bansalMaria zannesCompany annual report on formPrecision pathology laboratory servicesLung center at penn highlands healthcareLung innovations networkUs department of defenseAffinity technologies incLaboratory developed testWhile the companyPath lungCypath lungLung center

Medical Director of Pennsylvania s Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M D , Joins bioAffinity Technologies Medical and Scientific Advisory Board and Incorporates CyPath Lung into Medical Practice

SAN ANTONIO - bioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer including CyPath Lung, today announced that.

United statesSandeep bansalJulie anne overtonMaria zannesPrecision pathology laboratory servicesAffinity technologies incWhile the companyLung innovations networkLaboratory developed testCompany annual report on formAffinity technologyAffinity technologiesCypath lungMedical directorScientific advisory boardInnovations network

CMS Posts Final Payment Determination for bioAffinity Technologies CyPath Lung Effective January 2024

SAN ANTONIO - bioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other lung diseases, today announced that the.

United statesJulie anne overtonMaria zannesWhile the companyUniversity of texas at san antonioCenters for medicareMedicare clinical lab fee scheduleAffinity technologies incCompany annual report on formAmerican medical associationMedicare advisory panel on clinical diagnostic laboratoryMedicare advisory panelLaboratory developed testMedicaid servicesPrecision pathology laboratory servicesLaboratory analyses

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

14.11.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three and nine months .

United statesUniversity of texas at san antonioMaria zannesMedicare advisory panel on clinical diagnostic laboratoryCompany as nationalCompany annual report on formCollege of american pathologistsClinical laboratory improvement amendmentsVillage oaks pathology services on septUs department of defenseAffinity technologies incAmerican medical associationPrecision pathology laboratory servicesCompany current reports on formExchange commissionMedicaid services

bioAffinity Technologies Reports First Quarter 2023 Financial Results

15.05.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three months ended March .

Hong kongUnited statesUniversity of texas at san antonioMaria zannesEuropean unionHavas health youAffinity technologies incOncoselect therapeuticsTrademark officePrecision pathology servicesTrinity life sciencesMichael doughertyChief financialHavas healthCypath lungNasdaq stock market